A pair of U.S. lawmakers wrote Pfizer chief executive officer Albert Bourla that he should “back off” from plans to charge Americans up to $130 for the company’s Covid-19 vaccine, a move they described as “pure and deadly greed.”
In their letter, U.S. Sen. Elizabeth Warren (D-Mass.) and Sen. Peter Welch (D-Vt.) argued the planned price tag is nearly four times the current $30 price paid by the U.S. government and also represents a 10,000% markup over what some researchers have calculated as the cost to produce the vaccine.
They demanded Bourla provide more information about its pricing and “unseemly profiteering.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect